|
| Press Releases |
|
 |
|
| Monday, July 19, 2021 |
|
|
君联资本投资企业“全版权”运营商读客文化成功登陆创业板 |
| 7月19日，君联资本所投企业读客文化（股票代码：301025）在创业板成功上市。读客文化本次公开发行4001万股，截至发稿股价报人民币31.66元/股，较发行价上涨约1942%，总市值约126亿。 more info >> |
|
|
君聯資本投資企業「全版權」運營商讀客文化成功登陸創業板 |
| 7月19日，君聯資本所投企業讀客文化（股票代碼：301025）在創業板成功上市。讀客文化本次公開發行4001萬股，截至發稿股價報人民幣31.66元/股，較發行價上漲約1942%，總市值約人民幣126億。 more info >> |
|
|
Dook Media, a Full Copyright Operator, invested by Legend Capital Successfully Listed on the China GEM |
| On July 19th, Dook Media Group Limited (stock code: 301025), invested by Legend Capital, was successfully listed on the Growth Enterprise Market in China. With public offering of 40.01 million shares, the stock closed at RMB31.66 per share, up 1942% from its initial price. Its total market value reached over RMB12.6 billion. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Legend Capital continues to be optimistic about technological innovation, with great opportunities in tech investment |
| On July 8-9, 2021, Richard Li, the President of Legend Capital, attended the 10th Private Equity Investment Summit Forum held by Noah Holdings and delivered a speech on the topic of technological innovation, sharing his views on information technology, biotechnology and new energy, as well as the long-term prospects. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AI+儲能：範式集團與海博思創成立合資公司 市場前景廣闊
Aug 6, 2025 00:08 HKT/SGT
|
|
|
NEFECON(R) Receives NMPA Approval for Production Expansion in China,as Everest Medicines Accelerates Accessibility and Capacity Efforts
Aug 5, 2025 23:22 HKT/SGT
|
|
|
港股機器人板塊升溫 首程控股領跑前線
Aug 5, 2025 23:20 HKT/SGT
|
|
|
Robot Boom in HK: Shoucheng Holdings at the Forefront
Aug 5, 2025 23:18 HKT/SGT
|
|
|
MHI Selected to Enter Next Stage Procurement Process for Australia's New General-Purpose Frigates
Aug 5, 2025 22:02 JST
|
|
|
三菱重工、豪州次期汎用フリゲートの共同開発・生産について発表
Aug 5, 2025 15:00: JST
|
|
|
AI+储能：范式集团与海博思创成立合资公司 市场前景广阔
Aug 5, 2025 14:50 HKT/SGT
|
|
|
港股机器人板块升温 首程控股领跑前线
Aug 5, 2025 14:32 HKT/SGT
|
|
|
Atlas Lithium 的 Neves 项目完成最终可行性研究，预估内部报酬率为 145%，回本期为 11 个月
Aug 5, 2025 13:00 HKT/SGT
|
|
|
Atlas Lithium 的 Neves 項目完成最終可行性研究，預估內部報酬率為 145%，回本期為 11 個月
Aug 5, 2025 13:00 HKT/SGT
|
|
|
全球首個IgA腎病對因治療藥物耐賦康®擴產獲批 雲頂新耀加速提升可及性與產能佈局
Aug 5, 2025 10:21 HKT/SGT
|
|
|
全球首个IgA肾病对因治疗药物耐赋康®扩产获批 云顶新耀加速提升可及性与产能布局
Aug 5, 2025 10:21 HKT/SGT
|
|
|
Atlas Lithium、ネベス・プロジェクトにおける確定的実現可能性調査を完了 IRR145%、11か月で回収可能と推定
Aug 5, 2025 10:00: JST
|
|
|
Atlas Lithium's Neves Project Completes Definitive Feasibility Study Estimating 145% IRR and 11-Month Payback
Aug 5, 2025 01:08: JST
|
|
|
旅行者醫療支援平台 Traveler Care 正式全球上線，協助旅遊保險公司減少 80% 急診索賠
Aug 4, 2025 23:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
